Profil:
Voxel SAVoxel medical posts PLN 27.6 mln in Q3 2025, slightly above expectations
Listed medical diagnostics services provider Voxel posted a PLN 27.6 million (EUR 6.5 mln) net profit and a PLN 50.7 million (EUR 12 mln) EBITDA in the third quarter of 2025, the company's financial report has shown. The results are slightly above the PAP Biznes consensus of a PLN 49.5 million (EUR 11.7 mln) EBITDA and a PLN 26.6 million (EUR 6.3 mln) net take.
Below are Voxel's results for the third quarter against the market expectations and previous results.
| Q3 2025 | results | consensus | difference | y/y | q/q | YTD 2025 | y/y |
| PLN mln | PLN mln | % | % | % | |||
| Revenues | 143 | 142.7 | 0.2% | 6.3% | 12.3% | 428.2 | 16.6% |
| EBITDA | 50.7 | 49.5 | 2.5% | 9.9% | 17.6% | 139.9 | 11.3% |
| EBIT | 36.7 | 35.4 | 3.6% | 7.1% | 24.1% | 99.0 | 9.1% |
| Attrib. net profit | 27.6 | 26.6 | 3.6% | 8.5% | 26,00% | 73.7 | 9.7% |
| EBITDA margin | 35.5% | 34.7% | 0.76 | 1.17 | 1.60 | 32.68% | -1.57 |
| EBIT margin | 25.6% | 24.8% | 0.81 | 0.19 | 2.45 | 23.13% | -1.59 |
| net margin | 19.3% | 18.7% | 0.61 | 0.40 | 2.10 | 17.22% | -1.08 |
alk/ ao/